From life-changing medical advancements to colorful auroras, this year has been packed with incredible science. It was hard ...

Monlunabant is a small molecule commercialized by Novo Nordisk, with a leading Phase II program in Diabetic Nephropathy.

Why pay $84,000 for a hepatitis C drug when you can make it at home? But such DIY chemistry raises safety concerns ...

Imagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...

A Cornerstone in Diabetes ManagementInsulin delivery devices market are innovative medical instruments designed to provide ...

Major media outlets are giving wall-to-wall coverage to UnitedHealthcare CEO Brian Thompson’s murder while taking millions in ...

As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.

Brian Thompson's murder is a grim symbol of a larger issue: the profit-driven healthcare system in the United States, where ...

Novo Nordisk to slash US prices of Tresiba and Fiasp insulins by over 70% from 2026, enhancing diabetes access. The company ...

While the federal and provincial governments have come to an agreement to provide access to drugs for rare diseases, neither ...

Kevin Schulman, a health economist at Stanford Graduate School of Business and Stanford School of Medicine, taught a course ...